Avoid carbonated beverages, high-fat or fried foods, artificial sweeteners (especially sugar alcohols), and initially limit high-fiber foods like beans and cruciferous vegetables
Glycine in semaglutide compounds serves as a stabilizer that helps maintain the medication integrity and may provide additional metabolic benefits
Orforglipron, Lilly's once-daily oral non-peptide GLP-1 agonist, helped overweight adults without diabetes lose 12.4% of their body weight over 72 weeks at the highest dose in a late-stage trial
Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew)
For people who use one of the two new GLP-1s, semaglutide (Wegovy) or tirzepatide (Zepbound) to lose weight, the results can vary from person to person
These findings highlight potential risks for patients undergoing surgery, especially concerning pulmonary aspiration during anesthesia